Connor Clark & Lunn Investment Management Ltd. Sells 55,441 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Connor Clark & Lunn Investment Management Ltd. reduced its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 43.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,021 shares of the semiconductor company’s stock after selling 55,441 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned 0.22% of Axcelis Technologies worth $7,551,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Signaturefd LLC lifted its stake in Axcelis Technologies by 348.9% in the 2nd quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 164 shares during the last quarter. Blue Trust Inc. raised its stake in Axcelis Technologies by 223.8% in the second quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after buying an additional 188 shares during the period. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Axcelis Technologies in the second quarter valued at approximately $39,000. Isthmus Partners LLC boosted its stake in shares of Axcelis Technologies by 87.3% during the 2nd quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock worth $47,000 after acquiring an additional 15,507 shares during the period. Finally, Meeder Asset Management Inc. acquired a new position in shares of Axcelis Technologies during the 2nd quarter worth approximately $69,000. Institutional investors and hedge funds own 89.98% of the company’s stock.

Axcelis Technologies Price Performance

NASDAQ:ACLS opened at $75.07 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.29 and a current ratio of 4.45. The firm has a market cap of $2.44 billion, a price-to-earnings ratio of 11.11, a P/E/G ratio of 2.19 and a beta of 1.60. Axcelis Technologies, Inc. has a 52 week low of $69.35 and a 52 week high of $158.61. The firm’s 50-day simple moving average is $92.56 and its 200 day simple moving average is $111.47.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. B. Riley reduced their price objective on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating for the company in a research report on Friday, August 2nd. Benchmark downgraded shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a report on Friday, November 8th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Axcelis Technologies has an average rating of “Moderate Buy” and an average target price of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.